📣 VC round data is live. Check it out!
- Public Comps
- Shinva
Shinva Valuation Multiples
Discover revenue and EBITDA valuation multiples for Shinva and similar public comparables like Butterfly Network, Sopharma, Integra Lifesciences, Avanos Medical and more.
Shinva Overview
About Shinva
Shinva Medical Instrument Co Ltd manufactures medical instruments in China. Its main products include sterilizers and testing products, radiotherapy and digital diagnosis equipment, surgical instruments and pharmaceutical machinery.
Founded
1993
HQ

Employees
1.4K
Website
Financials (LTM)
EV
$911M
Valuation Multiples
Start free trialShinva Financials
Shinva reported last 12-month revenue of $1B and EBITDA of $129M.
In the same LTM period, Shinva generated $365M in gross profit, $129M in EBITDA, and $79M in net income.
Revenue (LTM)
Shinva P&L
In the most recent fiscal year, Shinva reported revenue of $1B and EBITDA of $128M.
Shinva is profitable as of last fiscal year, with gross margin of 25%, EBITDA margin of 9%, and net margin of 5%.
Financial data powered by Morningstar, Inc.
Shinva Stock Performance
Shinva has current market cap of $1B, and enterprise value of $911M.
Market Cap Evolution
Shinva's stock price is $1.98.
Shinva share price decreased by 0.5% in the last 30 days, and by 10.1% in the last year.
Shinva has an EPS (earnings per share) of $0.13.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $911M | $1B | -1.7% | -0.5% | -5.6% | -10.1% | $0.13 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialShinva Valuation Multiples
Shinva trades at 0.6x EV/Revenue multiple, and 7.1x EV/EBITDA.
EV / Revenue (LTM)
Shinva Financial Valuation Multiples
As of June 3, 2026, Shinva has market cap of $1B and EV of $911M.
Shinva has a P/E ratio of 15.3x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Shinva Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Shinva Margins & Growth Rates
Shinva grew revenue by 2% and EBITDA by 4% in the last fiscal year.
In the most recent fiscal year, Shinva reported gross margin of 25%, EBITDA margin of 9%, and net margin of 5%.
Shinva Margins
Shinva Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Shinva Operational KPIs
Shinva's revenue per employee in the last FY averaged $1.1M, while opex per employee averaged $0.2M for the same period.
Shinva's Rule of 40 is 11% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Shinva's Rule of X is 14% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Shinva Competitors
Shinva competitors include Butterfly Network, Sopharma, Integra Lifesciences, Avanos Medical, Inspire Medical Systems, Alphatec Holdings, iRadimed, Medartis, Enovis and Tandem Diabetes Care.
Most Shinva public comparables operate across Medical Devices, Medical Supplies, DeepTech and HealthTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 11.1x | 10.1x | (40.7x) | (43.1x) | |||
| 0.8x | - | 7.6x | - | |||
| 1.8x | 1.8x | 9.5x | 9.3x | |||
| 1.8x | 1.8x | 14.3x | 14.0x | |||
| 1.0x | 1.0x | 4.5x | 4.8x | |||
| 2.1x | 2.0x | 17.3x | 14.6x | |||
| 13.1x | 12.6x | 40.2x | 37.8x | |||
| 3.8x | 3.5x | 22.5x | 21.3x | |||
This data is available for Pro users. Sign up to see all Shinva competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Shinva
| When was Shinva founded? | Shinva was founded in 1993. |
| Where is Shinva headquartered? | Shinva is headquartered in China. |
| How many employees does Shinva have? | As of today, Shinva has over 1K employees. |
| Is Shinva publicly listed? | Yes, Shinva is a public company listed on Shanghai Stock Exchange. |
| What is the stock symbol of Shinva? | Shinva trades under 600587 ticker. |
| When did Shinva go public? | Shinva went public in 2002. |
| Who are competitors of Shinva? | Shinva main competitors include Butterfly Network, Sopharma, Integra Lifesciences, Avanos Medical, Inspire Medical Systems, Alphatec Holdings, iRadimed, Medartis, Enovis, Tandem Diabetes Care. |
| What is the current market cap of Shinva? | Shinva's current market cap is $1B. |
| What is the current revenue of Shinva? | Shinva's last 12 months revenue is $1B. |
| What is the current revenue growth of Shinva? | Shinva revenue growth (NTM/LTM) is 3%. |
| What is the current EV/Revenue multiple of Shinva? | Current revenue multiple of Shinva is 0.6x. |
| What is the current EBITDA of Shinva? | Shinva's last 12 months EBITDA is $129M. |
| What is Shinva's EBITDA margin? | Shinva's last 12 months EBITDA margin is 9%. |
| What is the current EV/EBITDA multiple of Shinva? | Current EBITDA multiple of Shinva is 7.1x. |
| How many companies Shinva has acquired to date? | Shinva hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Shinva has invested to date? | Shinva hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Shinva
Lists including Shinva
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.